Alcon Operating Margin from 2010 to 2024

ALC Stock  USD 88.23  0.99  1.13%   
Alcon AG's Operating Profit Margin is increasing over the years with very volatile fluctuation. Overall, Operating Profit Margin is expected to go to 0.12 this year.
Check Alcon AG financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alcon AG's main balance sheet or income statement drivers, such as Interest Expense of 198.4 M, Total Revenue of 7.7 B or Gross Profit of 4.1 B, as well as many indicators such as Price To Sales Ratio of 3.4, Dividend Yield of 0.002 or PTB Ratio of 1.23. Alcon financial statements analysis is a perfect complement when working with Alcon AG Valuation or Volatility modules.
  
Check out the analysis of Alcon AG Correlation against competitors.
For information on how to trade Alcon Stock refer to our How to Trade Alcon Stock guide.

Latest Alcon AG's Operating Margin Growth Pattern

Below is the plot of the Operating Profit Margin of Alcon AG over the last few years. It is Alcon AG's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alcon AG's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.14 %10 Years Trend
Very volatile
   Operating Profit Margin   
       Timeline  

Alcon Operating Margin Regression Statistics

Arithmetic Mean0.04
Geometric Mean0.04
Coefficient Of Variation136.27
Mean Deviation0.05
Median0.06
Standard Deviation0.06
Sample Variance0
Range0.1905
R-Value0.06
Mean Square Error0
R-Squared0
Significance0.83
Slope0.0007
Total Sum of Squares0.04

Alcon Operating Margin History

2024 0.12
2023 0.11
2022 0.0771
2021 0.07
2020 -0.0705
2019 -0.0249
2018 -0.0347

About Alcon AG Financial Statements

Alcon AG stakeholders use historical fundamental indicators, such as Alcon AG's Operating Margin, to determine how well the company is positioned to perform in the future. Although Alcon AG investors may analyze each financial statement separately, they are all interrelated. For example, changes in Alcon AG's assets and liabilities are reflected in the revenues and expenses on Alcon AG's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Alcon AG. Please read more on our technical analysis and fundamental analysis pages.
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland. Alcon operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 24000 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Alcon AG offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alcon AG's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alcon Ag Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alcon Ag Stock:
Check out the analysis of Alcon AG Correlation against competitors.
For information on how to trade Alcon Stock refer to our How to Trade Alcon Stock guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alcon AG. If investors know Alcon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alcon AG listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.293
Earnings Share
2.34
Revenue Per Share
19.757
Quarterly Revenue Growth
0.054
Return On Assets
0.0255
The market value of Alcon AG is measured differently than its book value, which is the value of Alcon that is recorded on the company's balance sheet. Investors also form their own opinion of Alcon AG's value that differs from its market value or its book value, called intrinsic value, which is Alcon AG's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alcon AG's market value can be influenced by many factors that don't directly affect Alcon AG's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alcon AG's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alcon AG is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alcon AG's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.